Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 10, 2016
Patent Application Number
14352120
Date Filed
October 23, 2012
Patent Citations Received
Patent Primary Examiner
Patent abstract
The disclosure relates to agents that inhibit the activity of osteoprotegerin and their use in the treatment of pulmonary hypertension.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
